Is resitance to anti-HCV drugs "real"? After a decade of treatment, a collboration of scientists and clinicians from 17 countries collated their data for the most comprehensive answer to-date for this question.
#HCV#EASL#SHARED#JHEPreports
https://t.co/AA0jHcI2nI
A detailed analysis of how Hepatitis C virus variants emerge and diminish within a single infected patient overtime - a feat possible with tools we developed over the last 5 years #ONT#Oxfordnanopore#NanoQ#HCV
https://t.co/3yvfzP6Tjs
More severe COVID may also lead to better immunity, at least up to 12 months post-infection - Our latest publication (NB - This is pre-Omicron data)
#COVID19
https://t.co/X3JJrnswCc
Data on post-thrombolysis outcomes for patients in South Asian countries are scanty at best. We recently published some much needed data from Sri Lanka on this.
https://t.co/mzXZ3bE45k
How common is plasma leakage in dengue? An all important question for which the answer is not straight forward - we discuss the reasons here in our latest work. #denguefever#Colombodenguestudy
https://t.co/s0oXD5AQEN
Is it cheaper to exclude a diagnosis of dengue upfront, than treat everyone on clinical suspicion?
-Depends on who is testing
#denguefever#Colombodenguestudy#PLOSONE: Direct costs of managing in-ward dengue patients in Sri Lanka: A prospective study https://t.co/8GC1uVxhIv
SHARED: An International Collaboration to Unravel Hepatitis C Resistance https://t.co/7ckWMB6gJq ##mdpiviruses via @VirusesMDPI
A global collaboration for tracking resistant mutations in hepatitis C virus against directly acting antivirals
#HCV#antivirals
Developing tools to understand how HCV, a carcinogenic virus tackles the human immune system successfully (on most occassions)
#HCV#antibodies#Immunity https://t.co/r6SJzYPMUr
For how long does COVID-19 immunity last after natural infection? At least for 6 months and possibly more, driven by memory B cells (Our latest paper, hot off the press) #COVID19 https://t.co/PoheTEyiGI
Multiple genomic variants of RNA viruses exist in a single infected person. Scientists assume a representative sequence per host as these variants cannot be sequenced in whole……until now; with @PDawgzGG@martinalexsmith@DrKirston@nasirriaz
https://t.co/PkmGnjMm8D
Adikari et al. develop a methodology to sequence near full-length Dengue virus genomes as intact molecules. Thanks for using @vipr_db! @chaturod@thiruni1@PDawgzGG@UNSW
https://t.co/9yqXonIsdA
A pre-pandemic Dengue virus sequencing project we were involved in was recently published. Led by @chaturod@thiruni1 & @nasirriaz with help from the magical pipette of @DrKirston
https://t.co/ETOMlV6Nm4
Our new method makes it much easier to generate dengue genomes. There is also a cool new tool to identify within-host variants #Dengue#Colombodenguestudy#ONT
https://t.co/4akqlCQvdT
A major obstacle for vaccine development in hepatitis C is the variability of the virus genome. We have found that this variability differs based on the type virus and a persons genetic make up
#HCV#viruses#shannonentropy#cirrhosis
https://t.co/owcZGUAPAM